HSDT Solana Company
Solana Company (HSDT) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is $0.02 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +31.8% since its last earnings release on August 14, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Solana Company
Helius Medical Technologies is a neurotech company focused on neurological wellness. The Company’s purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company’s first commercial product is the Portable Neuromodulation Stimulator (PoNS™).
Sector
Financials
Industry
Diversified Investments